Shedding Light on the Dual Challenges of Sarcoidosis and ILD - Dr Asmita Mehta Dr Asmita Mehta1 March 2024 12:30 PM ISTSarcoidosis is a rare inflammatory disease affecting multiple organs, most commonly the lungs. This occurs when inflammatory cells aggregate to form...
Researchers identify incidence and risk factors for new-onset interstitial lung disease in systemic sclerosis Isra Zaman11 Nov 2023 9:00 AM ISTNew research at ACR Convergence 2023, the American College of Rheumatology's (ACR) annual meeting, reports the incidence and risk factors for...
Tofacitinib tied to reduced incidence of ILD among Rheumatoid arthritis patients Aditi18 May 2023 8:00 PM ISTAn Original Investigation in Rheumatology published in JAMA Network Open has found a reduced risk of developing interstitial lung disease (ILD) in...
Fatigue Severity Scale Valid Tool for assessing fatigue in patients with ILD Dr. Mahalakshmi Sivashankaran17 May 2023 8:00 PM ISTUSA: A recent study published in the American Journal of Respiratory and Critical Care Medicine has found that the fatigue severity scale (FSS) is a...
All About Interstitial Lung Disease (ILD) - Dr Srinivas Rajagopala Dr Srinivas Rajagopala30 March 2023 3:59 PM ISTQ1. What does the Lung Interstitium contain and do? The Lung interstitium has small airways called bronchioles to bring in air to the alveolus;...
Hospitalized COVID-19 Pneumonia Patients may have residual ILD Dr.Niharika Harsha B15 Sept 2022 8:00 PM ISTOne-third of Patients with COVID-19 Pneumonia developed residual ILD, 3-6 months post-discharge as per a recent study. This was published in the...
FDA approves treprostinil dry powder inhaler for treatment of PAH Dr. Kamal Kant Kohli27 May 2022 10:15 AM ISTThe Food and Drug Administration (FDA) has granted approval to Tyvaso DPI (treprostinil) inhalation powder for treating pulmonary arterial...
Disease Review: Understanding Incidence of Idiopathic pulmonary fibrosis (IPF) in India, Diagnosis and Treatment Dr. Anil Mehndiratta10 Jan 2022 12:24 PM ISTIdiopathic pulmonary fibrosis (IPF), previously known as "Hamman Rich syndrome", "cryptogenic fibrosing alveolitis", and "cirrhosis of the lung", is a...
Nasal High Flow Oxygen Increases Exercise Tolerance in ILD Patients: Study MD Bureau3 Aug 2021 9:00 AM ISTNasal High Flow Oxygen increases exercise tolerance and endurance time in patients with Interstitial Lung Disease, finds study.
FDA approves first oral treatment for ILD Dr. Kamal Kant Kohli11 March 2020 11:30 AM ISTThe U.S. Food and Drug Administration has approved first treatment in form of Ofev (nintedanib) oral capsules to treat patients with chronic fibrosing...
Chennai : Doctors at Fortis Malar performs successful bilateral lung transplant in Ukraine patient savita thakur thakur1 Sept 2016 3:11 PM ISTChennai : Fortis Malar team conducted a successful bilateral lung transplant on a patient, Kravchenko Igor from Ukraine. The challenging surgery of...
